Literature DB >> 20930598

Respiratory alkalosis and metabolic acidosis in a child treated with sulthiame.

Avichai Weissbach1, Irit Tirosh, Oded Scheuerman, Vered Hoffer, Ben Zion Garty.   

Abstract

OBJECTIVES: To report on severe acid-base disturbance in a child with symptomatic epilepsy treated with sulthiame.
RESULTS: A 9.5-year-old boy with chronic generalized tonic-clonic seizures was treated with carbamazepine and valproic acid. Because of poor seizure control, sulthiame was added to the treatment. Two months later, he presented at the emergency department with severe weakness, headache, dizziness, dyspnea, anorexia, and confusional state. Arterial blood gas analysis showed mixed respiratory alkalosis with high anion gap metabolic acidosis. Sulthiame-induced acid-base disturbance was suspected. The drug was withheld for the first 24 hours and then restarted at a reduced dosage. The arterial blood gases gradually normalized, the confusion disappeared, and the patient was discharged home.Three months later, 4 weeks after an increase in sulthiame dosage, the patient was once again admitted with the same clinical picture. Improvement was noted after the drug dosage was reduced.
CONCLUSIONS: This is the first report of mixed respiratory alkalosis and metabolic acidosis in a child treated with sulthiame. Monitoring of the acid-base status should be considered in patients treated with sulthiame.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930598     DOI: 10.1097/PEC.0b013e3181f39b4b

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  6 in total

1.  Sulthiame add-on treatment in children with epileptic encephalopathy with status epilepticus: an efficacy analysis in etiologic subgroups.

Authors:  Seda Kanmaz; Erdem Simsek; Hepsen Mine Serin; Sanem Yilmaz; Gul Aktan; Hasan Tekgul; Sarenur Gokben
Journal:  Neurol Sci       Date:  2020-06-26       Impact factor: 3.307

Review 2.  Sulthiame monotherapy for epilepsy.

Authors:  Philip Milburn-McNulty; Graham Powell; Graeme J Sills; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2014-03-09

Review 3.  Sulthiame monotherapy for epilepsy.

Authors:  Philip Milburn-McNulty; Mariangela Panebianco; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2021-09-23

4.  Sulthiame add-on therapy for epilepsy.

Authors:  Rebecca Bresnahan; Kirsty J Martin-McGill; Philip Milburn-McNulty; Graham Powell; Graeme J Sills; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-08-27

5.  Sulthiame impairs mitochondrial function in vitro and may trigger onset of visual loss in Leber hereditary optic neuropathy.

Authors:  Marie-Christine Reinert; David Pacheu-Grau; Claudia B Catarino; Thomas Klopstock; Andreas Ohlenbusch; Michael Schittkowski; Ekkehard Wilichowski; Peter Rehling; Knut Brockmann
Journal:  Orphanet J Rare Dis       Date:  2021-02-04       Impact factor: 4.123

6.  Stability-Indicating High-Performance Liquid Chromatography Assay for the Determination of Sulthiame in Pharmaceutical Dosage Forms.

Authors:  Ammar Haidar; Sofiane Kabiche; Elyes Majoul; Issa-Bella Balde; Jean-Eudes Fontan; Salvatore Cisternino; Joël Schlatter
Journal:  Anal Chem Insights       Date:  2016-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.